ESPE Abstracts (2014) 82 WG2.1

Technological Horizon for the Treatment of Diabetes

Moshe Phillip


Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel


The daily treatment of pediatric patients with diabetes is challenging for patients, parents and medical teams. This is probably the reason why most patients all over the world do not meet the targets of glucose control defined by world organizations like ISPAD, EASD and the ADA as the safe zone for preventing complications, extending life expectancy and improving quality of life. New emerging technologies are in the pipeline of both academic centers and industry that promise to change the way diabetes is treated.

Advisors, coachers, calculators, new medications, automatic systems, cellular manipulation, genetic engineering, telemedicine and automatic insulin delivery systems are all in the horizon for patients with diabetes to cure or at least alleviate the burden of the patients’ shoulders, parents and care givers in their constant attempts to navigate the glucose control towards the safe range of diabetes control.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts